Large
accelerated filer
|
o
|
Accelerated
filer
|
o
|
|
Non-accelerated
filer
|
o
|
Smaller
reporting company
|
x
|
MATECH
CORP.
|
||||
(A
Development Stage Company)
|
||||
CONDENSED
CONSOLIDATED BALANCE SHEET
|
||||
September
30,
|
||||
2008
|
||||
(Unaudited)
|
||||
ASSETS
|
||||
Current
assets:
|
||||
Cash
and cash equivalents
|
$ | 441,076 | ||
Accounts
receivable
|
15,620 | |||
Inventories
|
156,054 | |||
Prepaid
expenses and other current assets
|
70,423 | |||
Total
current assets
|
683,173 | |||
Property
and equipment, net
|
84,590 | |||
Deferred
loan fees
|
356,708 | |||
Intangible
assets, net
|
2,033 | |||
Deposit
|
2,348 | |||
$ | 1,128,852 |
MATECH
CORP.
|
||||
(A
Development Stage Company)
|
||||
CONDENSED
CONSOLIDATED BALANCE SHEET - Continued
|
||||
September
30,
|
||||
2008
|
||||
(Unaudited)
|
||||
LIABILITIES
AND STOCKHOLDERS' DEFICIT
|
||||
Current liabilities:
|
||||
Accounts payable and accrued expenses
|
$ | 646,208 | ||
Current portion of research and development sponsorship
payable
|
25,000 | |||
Notes payable - current portion
|
294,567 | |||
Total current liabilities
|
965,775 | |||
Accrued legal settlement
|
222,852 | |||
Research and development sponsorship payable, net of current
portion
|
768,934 | |||
Convertible debentures and accrued interest payable, net of
discounts
|
1,280,201 | |||
Derivative and warrant liabilities
|
3,500,035 | |||
5,772,022 | ||||
Total liabilities
|
6,737,797 | |||
Minority interest in consolidated subsidiary
|
825 | |||
Commitments and contingencies
|
||||
Stockholders' deficit:
|
||||
Class A preferred stock, $0.001 par value, liquidation
preference
|
||||
of $720 per share; 350,000 shares authorized; 337 shares
issued
|
||||
and outstanding as of September 30, 2008
|
- | |||
Class
B preferred stock, $0.001 par value, liquidation preference
of
|
||||
$10,000 per share; 15 shares authorized; none issued
and
|
||||
outstanding as of September 30, 2008
|
- | |||
Class C preferred stock, $0.001 par value, liquidation preference
of
|
||||
$0.001 per share; 25,000,000 shares authorized; 1,517 shares
issued
|
||||
and outstanding as of September 30,2008
|
1 | |||
Class D preferred stock, $0.001 par value, liquidation preference
of
|
||||
$0.001 per share; 20,000,000 shares authorized; none shares
issued
|
||||
and outstanding as of September 30,2008
|
- | |||
Class E convertible preferred stock, $0.001 par value, no
liquidation
|
||||
preference; 60,000 shares authorized; 49,200 shares issued
and
|
||||
outstanding as of September 30,2008
|
49 | |||
Class A Common Stock, $0.001 par value, 600,000,000 shares
|
authorized; 205,736,018 shares issued and 186,567,253 shares
outstanding
|
||||
at
September 30,2008
|
186,567 | |||
Class B Common Stock, $0.001 par value, 600,000 shares
authorized,
|
||||
issued
and outstanding as of September 30,2008
|
600 | |||
Warrants subscribed
|
10,000 | |||
Additional paid-in-capital
|
326,742,387 | |||
Deficit accumulated during the development stage
|
(332,547,374 | ) | ||
Treasury stock (200,000 shares at cost at September 30,
2008)
|
(2,000 | ) | ||
Total stockholders' deficit
|
(5,609,770 | ) | ||
$ | 1,128,852 |
MATECH
CORP.
|
||||||||||||||||||||
(A
Development Stage Company)
|
||||||||||||||||||||
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||||||||||||||
From
October 21, 1983
|
||||||||||||||||||||
For
the Three Months Ended
|
For
the Nine Months Ended
|
(Inception)
|
||||||||||||||||||
September
30,
|
September
30,
|
through
|
||||||||||||||||||
2007
|
2008
|
2007
|
2008
|
September
30, 2008
|
||||||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||||
Revenues:
|
||||||||||||||||||||
Research
and development
|
$ | - | $ | - | $ | - | $ | - | $ | 5,392,085 | ||||||||||
Revenue
from bridge testing
|
80,000 | 29,269 | 146,745 | 30,359 | 348,983 | |||||||||||||||
Other
|
- | - | - | - | 274,125 | |||||||||||||||
Total
revenues
|
80,000 | 29,269 | 146,745 | 30,359 | 6,015,193 | |||||||||||||||
Costs
and expenses
|
||||||||||||||||||||
Research
and development
|
21,266 | 113,588 | 3,533,343 | 423,428 | 20,986,417 | |||||||||||||||
General
and administrative
|
20,133,368 | 773,334 | 82,608,673 | 26,619,102 | 330,114,343 | |||||||||||||||
Modification
of research and development sponsorship agreement
|
- | - | - | - | 5,963,120 | |||||||||||||||
Loss
on Settlement of lawsuits
|
- | - | - | - | 1,267,244 | |||||||||||||||
Total
Costs and expenses
|
20,154,634 | 886,922 | 86,142,016 | 27,042,530 | 358,331,124 | |||||||||||||||
Loss
from operations
|
(20,074,634 | ) | (857,653 | ) | (85,995,271 | ) | (27,012,171 | ) | (352,315,931 | ) | ||||||||||
Other
income (expense):
|
||||||||||||||||||||
Loss
on modification of convertible debt
|
- | - | - | (964,730 | ) | (378,485 | ) | |||||||||||||
Loss
on subscription receivables
|
- | - | - | - | (1,368,555 | ) | ||||||||||||||
Interest
expense
|
(423,510 | ) | (831,678 | ) | (2,014,161 | ) | (1,808,697 | ) | (13,548,890 | ) |
Other-than-temporary
impairment of marketable securities available for sale
|
(2,310,000 | ) | - | (10,254,000 | ) | - | (9,785,947 | ) | ||||||||||||
Net
unrealized and realized loss of marketable securities
|
(335 | ) | (612,553 | ) | (8 | ) | (9,398,226 | ) | ||||||||||||
Change
in fair value of investments derivative liability
|
- | - | - | - | (210,953 | ) | ||||||||||||||
Change
in fair value of derivative and warrant liabilities
|
(8,414,694 | ) | 72,975,655 | 14,505,323 | 10,431,555 | 54,018,644 | ||||||||||||||
Interest
income
|
19,304 | 356 | 35,270 | 15,879 | 482,761 | |||||||||||||||
Other
|
- | - | - | - | (25,992 | ) | ||||||||||||||
Other
income (expense), net
|
(11,129,235 | ) | 72,144,333 | 1,659,879 | 7,673,999 | 19,784,357 | ||||||||||||||
Income
(loss) before provision for income taxes
|
(31,203,869 | ) | 71,286,680 | (84,335,392 | ) | (19,338,172 | ) | (332,531,574 | ) | |||||||||||
Provision
for income taxes
|
- | - | (800 | ) | (800 | ) | (15,800 | ) | ||||||||||||
Net
Income (loss)
|
$ | (31,203,869 | ) | $ | 71,286,680 | $ | (84,336,192 | ) | $ | (19,338,972 | ) | $ | (332,547,374 | ) | ||||||
Per
share data:
|
||||||||||||||||||||
Basic
and diluted net loss per share
|
$ | (0.25 | ) | $ | 0.41 | $ | (0.83 | ) | $ | (0.12 | ) | |||||||||
Weighted
average Class A common shares outstanding - basic and
diluted
|
124,276,444 | 175,239,753 | 101,671,169 | 156,873,303 |
MATECH
CORP.
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
CONSOLIDATED
STATEMENTS OF COMPREHENSIVE INCOME
(LOSS)
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Nine Months Ended
|
(Inception)
|
|||||||||||
September
30,
|
through
|
|||||||||||
2007
|
2008
|
September
30, 2008
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
Net
income (loss)
|
$ | (31,203,869 | ) | $ | 71,286,680 | $ | (332,547,374 | ) | ||||
Other
comprehensive loss:
|
||||||||||||
Temporary
increase (decrease) in market
|
||||||||||||
value of securities available for sale
|
- | - | ||||||||||
Reclassification
to other-than-temporary
|
||||||||||||
impairment
of marketable securities
|
||||||||||||
available
for sale
|
- | - | - | |||||||||
- | - | - | ||||||||||
Net
comprehensive income (loss)
|
$ | (31,203,869 | ) | $ | 71,286,680 | $ | (332,547,374 | ) |
MATECH
CORP.
|
|
(A
Development Stage Company)
|
|
CONDENSED
CONSOLIDATED STATEMENTS OF CASH
FLOWS
|
From
October 21, 1983
|
||||||||||||
For
the Nine Months Ended
|
(Inception)
|
|||||||||||
September
30,
|
through
|
|||||||||||
2007
|
2008
|
September
30, 2008
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
(Restated)
|
||||||||||||
Cash
flows from operating activities:
|
||||||||||||
Net
loss
|
$ | (84,336,192 | ) | $ | (19,338,972 | ) | $ | (332,547,374 | ) | |||
Adjustments
to reconcile net loss to net cash used in
operating activities:
|
||||||||||||
(Gain)
loss on modification of convertible debt
|
- | 964,730 | 378,485 | |||||||||
Impairment
loss
|
19,294,877 | - | 21,391,528 | |||||||||
Loss
on charge off of subscription receivables
|
- | - | 1,368,555 | |||||||||
Issuance
of common stock for services
|
19,519,168 | 4,729,541 | 211,214,381 | |||||||||
Increase
in debt for services and fees
|
- | 4,456,625 | ||||||||||
Officer's
stock based compensation
|
45,000,000 | 19,885,333 | 86,460,675 | |||||||||
Issuance
of common stock for modification of
|
||||||||||||
research and development sponsorship agreement
|
- | - | 7,738,400 | |||||||||
Change
in fair value of derivative and warrant liabilities
|
(14,505,323 | ) | (10,431,555 | ) | (51,783,444 | ) | ||||||
Net
realized and unrealized loss on marketable securities
|
612,553 | - | 7,895,705 | |||||||||
Other-than-temporary
impairment of marketablesecurities available for
sale
|
10,254,000 | - | 9,785,946 | |||||||||
Legal
fees incurred for note payable
|
1,456,142 | |||||||||||
Accrued
interest expense added to principal
|
- | 272,077 | 1,767,082 | |||||||||
Amortization
of discount on convertible debentures
|
1,765,110 | 1,497,617 | 11,603,894 | |||||||||
Change
in fair value of investments derivative liability
|
- | - | 3,223,323 | |||||||||
Accrued
interest income added to principal
|
- | (656 | ) | (305,654 | ) | |||||||
Depreciation
and amortization
|
6,605 | 15,931 | 243,715 |
Other
non-cash adjustments
|
- | - | (114,730 | ) | ||||||||
(Increase)
decrease in trade receivables
|
14,787 | 93,041 | (65,948 | ) | ||||||||
(Increase)
decrease in inventories
|
(69,266 | ) | (93,838 | ) | (156,054 | ) | ||||||
(Increase)
decrease in prepaid expenses and othercurrent
assets
|
7,659 | 5,483 | 248,056 | |||||||||
Increase
in deposits
|
- | - | (2,348 | ) | ||||||||
(Decrease)
increase in accounts payable and accruedexpenses
|
(14,942 | ) | 19,443 | 2,528,338 | ||||||||
Net
cash used in operating activities
|
(2,450,964 | ) | (2,381,825 | ) | (13,214,702 | ) | ||||||
Cash
flows from investing activities:
|
||||||||||||
Proceeds
from the sale of marketable securities
|
137,174 | 300,000 | 3,758,476 | |||||||||
Purchase
of marketable securities
|
(302,038 | ) | - | (2,206,379 | ) | |||||||
Investment
in certificate of deposits and commercial paper
|
(1,650,000 | ) | (565,000 | ) | (1,965,000 | ) | ||||||
Maturities
of certificate of deposits and commercial paper
|
400,000 | 1,565,000 | 1,965,000 | |||||||||
Payment
received on officer loans
|
- | - | 876,255 | |||||||||
Funds
advanced to officers
|
- | - | (549,379 | ) | ||||||||
Proceeds
received in acquisition of consolidated subsidiaries
|
600,000 | - | 600,000 | |||||||||
Purchase
of property and equipment
|
(50,469 | ) | (17,167 | ) | (373,419 | ) | ||||||
Investment
in joint ventures
|
- | - | (102,069 | ) | ||||||||
Proceeds
from foreclosure
|
- | - | 44,450 | |||||||||
Proceeds
from the sale of property and equipment
|
- | - | 19,250 | |||||||||
Payment
for license agreement
|
- | - | (6,250 | ) | ||||||||
Net
cash provided (used) by investing activities
|
(865,333 | ) | 1,282,833 | 2,060,935 |
MATECH
CORP.
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
CONSOLIDATED
STATEMENTS OF CASH FLOWS - Continued
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Nine Months Ended
|
(Inception)
|
|||||||||||
September
30,
|
through
|
|||||||||||
2007
|
2008
|
September
30, 2008
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
(Restated)
|
||||||||||||
Cash
flow from financing activities:
|
||||||||||||
Proceeds
from the sale of common stock and warrants
|
$ | 4,079,935 | $ | 18,624 | $ | 9,464,577 | ||||||
Proceeds
from convertible debentures and other notes
payable
|
200,000 | 1,115,000 | 3,162,766 | |||||||||
Proceeds
from the sale of preferred stock
|
- | - | 473,005 | |||||||||
Loan
fees incurred on debt financing
|
(375,000 | ) | (375,000 | ) | ||||||||
Costs
incurred in offerings
|
- | - | (1,130,932 | ) | ||||||||
Capital
contributions
|
- | - | 301,068 | |||||||||
Purchase
of treasury stock
|
(55,650 | ) | (3,266 | ) | (170,641 | ) | ||||||
Principal
reduction on notes payable
|
(50,000 | ) | (25,000 | ) | (125,000 | ) | ||||||
Payment
on proposed reorganization
|
- | - | (5,000 | ) | ||||||||
Net
cash provided by (used in) financing activities
|
4,174,285 | 730,358 | 11,594,843 | |||||||||
Net
change in cash and cash equivalents
|
857,988 | (368,634 | ) | 441,076 | ||||||||
Cash
and cash equivalents, beginning of period
|
129,296 | 809,710 | - | |||||||||
Cash
and cash equivalents, end of period
|
$ | 987,284 | $ | 441,076 | $ | 441,076 | ||||||
Supplemental
disclosure of cash flow information:
|
||||||||||||
Interest
paid during the period
|
$ | 2,669 | $ | 20,281 | ||||||||
Income
taxes paid during the period
|
$ | 800 | $ | 800 |
Supplemental
disclosures of non-cash investing and financing
activities:
|
||||||||||||||||||||
2008
|
||||||||||||||||||||
Effective
June 16, 2008, the Company entered into an agreement with Palisades
Capital, LLC to modify the terms of
|
||||||||||||||||||||
the
convertible debt due them. In connection with the modification, the
Company recorded a loss from the
|
||||||||||||||||||||
modification
of the debt in the amount of $964,730. The Company also accrued a
derivative liability in
|
||||||||||||||||||||
connection
with the modification in the amount of $4,254,301. (See Note
10.)
|
||||||||||||||||||||
During
the nine months ended September 30, 2008, the Company issued 34,229,612
shares of its Class A common shares in
|
||||||||||||||||||||
the
conversion of $633,271 of convertible debt.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008, the Company issued 13,249,167
shares of its Class A common stock
|
||||||||||||||||||||
for
consulting services valued at $3,674,940.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008, the Company issued 378,491
shares of its Class A common stock
|
||||||||||||||||||||
pursuant
to the anti-dilution provisions of a settlement agreement.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008. a former employee and consultant
returned a total of 700,000 shares
|
||||||||||||||||||||
of
the Company's Class A common stock to treasury which were subsequently
cancelled.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008. the Company's president returned
30,000,000 shares of the Company's
|
||||||||||||||||||||
Class
A common stock to treasury which were subsequently
cancelled.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008, the Company issued 34,500,000
shares of its Class A common stock
|
||||||||||||||||||||
in
consideration of the exercise of cashless warrants. The Company accrued a
derivative liability in connection with the
|
||||||||||||||||||||
granting
of the warrants, which had a balance of $1,151,900 on the date of
exercise. The liability balance was credited to equity.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008, the Company issued 77,600 shares
of its Class A common stock for $18,624.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008, the Company issued 8,577,907
shares of the Company's common stock
|
||||||||||||||||||||
through
the conversion of 5,750 shares of the Company's Class E preferred
shares.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008, the Company's contingent
obligation to StephenMr. Beck under a settlement
|
||||||||||||||||||||
agreement
was reduced to $0, therefore the Company reduced its legal settlement
liability by the remaining accrued provision of
|
||||||||||||||||||||
$230,000,
which was credited to equity.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008, the Company obtained $55,000
through the issuance of convertible debt. In connection
|
||||||||||||||||||||
with
this debt, the Company recognized a beneficial conversion feature of
$28,140 that was credited to equity.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008, the Company obtained $1,000,000
through the issuance of convertible debt. In connection
|
||||||||||||||||||||
with
this debt, the Company recognized a beneficial conversion feature of
$715,266 that was credited to derivative and warrant
liabilities.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008, the Company recognized
compensation expense of $8,800 on the grant of
|
||||||||||||||||||||
options
to its employees and officers for the purchase of 800.000 shares of Class
A common stock. In addition, during the nine months
|
||||||||||||||||||||
the
Company granted options to its President for the purchase of 400,000,000
shares of its Class A common stock and granted
options
|
||||||||||||||||||||
to
a consultant to purchase 15,390,546 shares of its Class A common stock.
The Company recognized a derivative liability of
$6,400,000
|
||||||||||||||||||||
on
the granting of these options. In September 2008, the Company's President
returned options for 30,000,000 shares for cancellation.
|
||||||||||||||||||||
During
the nine months ended September 30, 2008, Palisades Capital, LLC paid
$60,000 on behalf of the Company
|
||||||||||||||||||||
to
a consultant. The $60,000 was added to the outstanding balance owed by the
Company to Palisades
|
||||||||||||||||||||
(See
Note 10.)
|
2007
|
|||||||||||||
During
the nine months ended September 30, 2007, the Company issued 11,311,424
shares of its Class A common stock
|
|||||||||||||
for
consulting and other services valued at $13,039,167. Included
in the 11,311,424 shares issued, 2,970,000 shares were
|
|||||||||||||
issued
to current officers of the company which were valued at
$4,398,500.
|
|||||||||||||
During
2007, the Company received $1,000,000 in consideration for issuing
2,500,000 units.
|
|||||||||||||
Each
unit consists of one share of the Company's Class A common stock and a
warrant to purchase
|
|||||||||||||
one
share of the Company's common stock at a price of $.60 per share. In
connection with private offering
|
|||||||||||||
the
Company paid $239,065 in fees and issued warrants to purchase 2,118,334
shares of the Company's
|
|||||||||||||
common
stock at a price of $.60 per share. In other private offerings, the
Company received $1,146,458
|
|||||||||||||
through
the issuance of 3,658,400 shares of common stock and warrants. Also during
the nine month period,
|
|||||||||||||
4,500,000
of common stock were issued through the exercise of the 4,500,000
warrants. Through the exercise
|
|||||||||||||
of
the warrants, the Company received $2,171,542 net of $528,458 in closing
costs.
|
|||||||||||||
In
connection with the above indicated private offering and related exercise
of the warrants, , the Company issued
|
|||||||||||||
1,507,500
shares of its Class A common stock. The 1,507,500 shares were valued at
$1,787,962 and charged against the
|
|||||||||||||
proceeds
received.
|
|||||||||||||
During
2007, the Company issued 50,000 shares its Class E Series convertible
preferred stock
|
|||||||||||||
in
exchange for receiving all of the outstanding shares of Stress Analysis
Technologies, Inc. ("SATI")
|
|||||||||||||
The
Company valued the acquisition at $975,000 and charged off $875,000 as it
deemed the intangible
|
|||||||||||||
assets
acquired to be fully impaired. In connection with this
transaction, the Company issued an additional
|
|||||||||||||
5,000
preferred shares valued at $97,500 for fees in connection with the
purchase. The $97,500 was
|
|||||||||||||
was
charged to equity.
|
|||||||||||||
During
2007, the Company issued 13,912,500 shares its common stock in the
acquisition of two subsidiaries.
|
|||||||||||||
The
assets acquired included $500,000 cash and licenses originally valued at
$18,880,875. The Company
|
|||||||||||||
charged
of the full costs assigned to the licenses as being
impaired.
|
|||||||||||||
In
connection with the above indicated private offering and related exercise
of the warrants, , the Company issued
|
|||||||||||||
1,507,500
shares of its Class A common stock. The 1,507,500 shares were valued at
$1,787,962 and charged against the
|
|||||||||||||
proceeds
received.
|
|||||||||||||
During
2007, the Company issued 10,000,000 shares its common stock in exchange
for 3,000,000 shares in
|
|||||||||||||
a
company whose shares are traded on the over-the-counter pink sheets. The
Company valued the shares received
|
|||||||||||||
at
$13,832,000. Subsequently, the transaction was rescinded and the
10,000,000 shares was returned to treasury
|
|||||||||||||
for
cancellation.
|
|||||||||||||
During
2007, the Company issued 10,800,000 shares in escrow pursuant to an
agreement it has with its Convertible debenture
|
|||||||||||||
holders.
During 2007, 10,050,000 shares of Class A common stock was
issued to certain debenture holders in the conversion
of
|
|||||||||||||
$1,005,000
of indebtedness. In addition, for services rendered by certain debenture
holders, the amount due on the debentures
|
|||||||||||||
was
increased by $1,100,000.
|
|||||||||||||
During
2007, the Company received 400,000 shares of prior issued common stock
which was subsequently cancelled.
|
|||||||||||||
During
2007, the Company acquired all of the outstanding shares of Bridge Concept
Inc., (“Bridge”) a corporation wholly owned by to its chief
engineer.
|
|||||||||||||
In
consideration for the shares received in Bridge, the Company issued
1,500,000 of its common stock and $37,500 which was paid
in
|
|||||||||||||
October
2007. The Company treated the acquisition as a related party transaction
and valued the entire acquisition at $39,000. The $39,000
|
|||||||||||||
was
assigned to the intellectual property of Bridge which was charged off to
operations as being impaired at September 30, 2007.
|
|||||||||||||
During
2007, the Company issued 2,352,249 shares of its common stock pursuant to
anti-dilution provisions in two agreements.
|
Finished goods |
$156,054
|
Office
and computer equipment
|
$ | 27,645 | ||
Manufacturing
equipment
|
230,522 | |||
258,167 | ||||
Less
accumulated depreciation
|
(173,577 | ) | ||
$ | 84,590 |
Period
of
Amortization
|
|||||
Patent
costs
|
17
years
|
$ | 28,494 | ||
License
agreement (see Note 7)
|
17
years
|
6,250 | |||
Website
|
5
years
|
5,200 | |||
39,944 | |||||
Less
accumulated amortization
|
(37,911 | ) | |||
$ | 2,033 |
2008
|
$ | 269 | ||
2009
|
$ | 1,076 | ||
2010
|
$ | 688 |
August 2,
2009
|
$ | 30,000 | ||
August 2,
2010
|
$ | 30,000 | ||
August 2, 2011 and each year
thereafter
|
$ | 50,000 |
January 29, 2010
|
$ | 21,000 | ||
January 29, 2011
|
$ | 32,000 | ||
January 29, 2012
|
$ | 42,000 |
January 1,
2009
|
$ | 10,000 | ||
January 1,
2010
|
$ | 20,000 | ||
January 1, 2011 and each year
thereafter
|
$ | 30,000 |
|
·
|
If
an Event of Default occurs under the Notes, and, if such Event of Default
is curable, such Event of Default continues for a period of 30 days
without being cured, then the 10% interest rate set forth in the Notes
will be increased to a Default Interest Rate of 18% per annum, and the
total balance of principal and accrued interest of the debentures shall
bear interest at the Default Interest Rate from the date of the occurrence
of such Event of Default.
|
|
·
|
In
addition, the entry of any judgment against the Company in excess of
$150,000, regardless of where, how, to whom or under what agreement such
liability arises, shall be an Event of Default under the Debentures,
unless (i) the Company pays such judgment within 60 days, or (ii) the
Company duly files an appeal of such judgment and execution of such
judgment is stayed. Finally, the entry of any order or judgment
in favor of any judgment creditor or other creditor attaching the assets
of the Company shall be an Event of Default under these
debentures. The conversion price of the debentures shall not be
at any time more than $0.10 per share, regardless of any combination of
shares of the Common Stock of the Company by reverse split or
otherwise.
|
|
·
|
If
an Event of Default occurs which is not cured within its applicable cure
period, if it is curable, the conversion price of these debentures after
such cure period has expired shall be reduced to half of the pre-Event of
Default conversion price. For clarification, if the conversion
price before an Event of Default were the lesser of 50% of market price or
$0.10, then the new conversion price would be the lesser of 25% of market
price or $0.05.
|
|
·
|
The
Company shall not issue any shares of its Class A Common Stock without a
legend stating that such shares may not be sold, transferred, pledged,
assigned or alienated for a period of at least one year following the date
of the issuance of such certificate, other than shares issued to or with
the written consent of the Holder. Notwithstanding the
foregoing, this provision shall not apply to (i) any shares issued to
purchasers in a financing where the Company receives net proceeds of at
least Five Hundred Thousand Dollars ($500,000) and the shares are sold for
not less than fifty percent (50%) of the closing price of the Company’s
common stock reported as of the closing date of such financing, and (ii)
any shares issued in connection with an acquisition of assets by the
Company where (a) the Company provides to the Holder a fairness opinion as
to the value of the acquired assets, and (b) the Company receives assets
that are worth at least fifty percent (50%) of the closing price per share
of the Company’s common stock as of the closing date of the
acquisition.
|
|
·
|
The
Company shall not enter into any agreement pursuant to which any party
other than the Holder has pre-emptive rights, the right to receive shares
of any class of securities of the Company for no additional consideration,
the right to receive a set, pre-determined percentage of the outstanding
shares of the Company for any period of time, or any other similar right
that has the effect of maintaining a set percentage of the issued and/or
outstanding shares of any class or classes of the capital stock of the
Company.
|
|
·
|
The
Company shall not enter into any agreement giving another party
anti-dilution protection unless (1) all shares received pursuant to such
provision are subject to a two-year lock-up from the date of issuance, and
(2) all such shares received are subject to a “dribble-out,” following the
two-year lock-up, restricting their sale to not more than 1/20th
of 5% of the previous month’s total trading volume in any single trading
day.
|
|
·
|
The
Company will not file any Registration Statement on Form S-8 nor issue any
shares registered on Form S-8, exclusive of shares currently registered on
Form S-8. However, when the total capital in the Company’s cash
account drops below $500,000, the Company may issue up to $30,000 worth of
securities registered on Form S-8, valued at the market price of the
common stock on the date of issuance, per month,
non-cumulative. Any issuance of S-8 shares will be supported by
an opinion of the Company’s counsel that such issuance complies in all
respects with federal securities laws. This opinion will be
provided to the legal representative of the Holder upon
request. Further, the Company will ensure that every entity or
individual that receives S-8 shares will be subject to a “dribble-out”
restricting their sale to not more than 1/20th
of 2% of the previous month’s total trading volume in any single trading
day, non-cumulative. The above described dribble-out is not an
aggregate sale restriction for all entities and individuals receiving S-8
shares;
|
|
·
|
The
Company has informed the Holder that it is considering completing a
one-for-one-thousand reverse split of its common stock, as described in an
Information Statement filed by the Company on or about April 25,
2008. The Company acknowledges that the conversion price of the
Debenture shall not be effected by any such reverse split, and that after
giving effect to such reverse split, the conversion price shall remain the
lesser of (i) 50% of the averaged ten closing prices for the Company’s
Common Stock for the ten trading days immediately preceding the Conversion
Date or (ii) $0.10. The Holder consents to this
action. The parties acknowledge that the Company is not
obligated to complete this reverse-split, or any reverse
split.
|
|
·
|
The
shareholder lockup provisions will not apply to up to any shares held by
Mr. Robert Bernstein, and sold by him personally in a bona-fide sale to an
unrelated, unaffiliated third party; provided, that (i) the number of
shares sold shall not exceed Two Million Five Hundred Thousand Dollars
($2,500,000) worth of stock, calculated based on the number of shares sold
multiplied by the closing price of the stock on the date such shares are
sold (if a market trade) or transferred on the books of the transfer agent
(if a private transfer). Once Two Million Five Hundred Thousand
Dollars ($2,500,000) worth of
|
stock has been sold as calculated above, the lockup on whatever remains of the shares owned by Mr. Bernstein (if any) goes back into effect. In this regard, if Mr. Bernstein sells any of his shares without legend, then he may only sell up to 1/20th of 5% of the previous month’s total trading volume in any single trading day, and he may not sell more than 1% of the issued and outstanding shares of Matech during any 90 day period. Further, if Mr. Bernstein sells any of his shares, he must have such shares transferred on the books of the transfer agent within five business days of the sale. Mr. Bernstein shall comply with all reporting requirements under Section 16 of the Securities Exchange Act of 1934, as amended. |
|
Fatigue
Fuse
|
EFS
|
Server
Array
System
|
X-Ray
Diffraction
Method
|
Nondestructive
evaluation
and
stimulate
industrial
innovation
|
|
Variety
Investments, Ltd.
|
5.00%
|
-
|
-
|
-
|
-
|
|
University
of Pennsylvania (see Note 7)
|
|
|
|
|
|
|
Net
sales of licensed products
|
-
|
7.00%
|
-
|
-
|
-
|
|
Net
sales of services
|
-
|
2.50%
|
-
|
-
|
-
|
|
NCAT
(see Note 7)
|
|
|
|
|||
Net
sales of licensed products
|
-
|
-
|
3.50%
|
-
|
-
|
|
Sublicensing
income
|
-
|
-
|
25.00%
|
-
|
-
|
|
ISIS (see
Note 7)
|
||||||
Net
sales of licensed products
|
-
|
-
|
-
|
2.5%
|
-
|
|
Sublicensing
income
|
-
|
-
|
-
|
25.00%
|
-
|
|
ISURF
(see Note 7) **
|
||||||
Net
sales of licensed products
|
-
|
-
|
-
|
-
|
3.0%
|
|
Sublicensing
income
|
-
|
-
|
-
|
-
|
25.00%
|
|
Shareholder
|
1.00%
|
0.50%
|
-
|
-
|
-
|
|
**
License cancelled in October 2008
|
Issued shares | 205,736,018 | |||
Less shares held in escrow: | ||||
Shares issued to the
Company and held in escrow
|
(3,357,397 | ) | ||
hares held in
escrow pursuant to agreement debenture holders
|
(8,000,000 | ) | ||
Contingent shares
held related to the Beck settlement
|
||||
for
antidilution purposes (see Note 10)
|
(7,805,368 | ) | ||
Other
|
(6,000 | ) | ||
(19,168,765 | ) | |||
Outstanding shares (including shares committed) | 186,567,253 |
Weighed
|
||||||||
Options/
|
Average
|
|||||||
Warrants
|
Exercise
|
|||||||
Outstanding
|
Price
|
|||||||
Balance
– December 31, 2007
|
5,118,334 | $ | 0.460 | |||||
Granted
*
|
456,190,546 | $ | 0.007 | |||||
Exercised
|
- | - | ||||||
Forfeited
|
- | - |
Balance
– June 30, 2008
|
461,308,880 | $ | . 012 | |||||
Granted
|
24,575,200 | $ | 0.176 | |||||
Exercised
|
- | - | ||||||
Forfeited
|
(304,618,334 | ) | $ | (.004 | ) | |||
Balance–
Sept 30, 2008
|
181,265,746 | $ | 0.034 |
|
*
|
Restated
to include the 40,000,000 warrants granted to Palisades and affiliate with
an effective date of June 16, 2008.
|
For
the Three Months Ended
|
For
the Nine Months Ended
|
|||||||||||||||
September
30,
|
September
30,
|
|||||||||||||||
2007
|
2008
|
2007
|
2008
|
|||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
|||||||||||||
Net
Income (loss)
|
$ | (31,203,869 | ) | $ | 5,629,997 | $ | (84,336,192 | ) | $ | (18,755,905 | ) | |||||
Per
share data:
|
||||||||||||||||
Basic
and diluted net loss per share
|
$ | (251.08 | ) | $ | 32.13 | $ | (829.50 | ) | $ | (119.56 | ) | |||||
Weighted average Class A common shares outstanding - basic and
diluted
|
124,276 | 175,240 | 101,671 | 156,873 |
For
the Three Months Ended
|
|||||||||||||
June
30, 2008
|
|||||||||||||
As
Originally Stated
|
Adjustments
|
As
Corrected
|
|||||||||||
Revenues:
|
|||||||||||||
Research
and development
|
$ | - | - | $ | - | ||||||||
Revenue
from bridge testing
|
- | - | - | ||||||||||
Other
|
- | - | - | ||||||||||
Total
revenues
|
- | - | - | ||||||||||
Costs
and expenses:
|
|||||||||||||
Research
and development
|
150,847 | - | 150,847 | ||||||||||
General
and administrative
|
5,517,443, | - | 5,517,443 | ||||||||||
Total
costs and expenses
|
5,668,290 | - | 5,668,290 | ||||||||||
Loss
from operations
|
(5,668,290 | ) | - | (5,668,290 | ) | ||||||||
Other
income (expense):
|
|||||||||||||
Interest
expense
|
(397,973 | ) |
1)
|
(208,055 | ) | (606,028 | ) |
Loss
on modification of convertible debt
|
- | 2) | (964,730 | ) | (964,730 | ) | |||||||||
Change
in fair value of derivative liabilities
|
(6,036,711 | ) | 3) | (65,066,965 | ) | (71,103,676 | ) | ||||||||
Interest
income
|
3,080 | - | 3,080 | ||||||||||||
Other
expense, net
|
- | - | - | ||||||||||||
Loss
before provision for income taxes
|
(12,099,894 | ) | (66,239,750 | ) | (78,339,644 | ) | |||||||||
Provision
for income taxes
|
- | - | - | ||||||||||||
Net
loss
|
$ | (12,099,894 | ) | $ | (66,239,750 | ) | $ | (78,339,644 | ) | ||||||
Per
share data:
|
|||||||||||||||
Basic
and diluted net loss per share
|
$ | (0.08 | ) | $ | (0.42 | ) | $ | (0.50 | ) | ||||||
Weighted
average Class A common shares outstanding - basic and
diluted
|
156,616,668 | 156,616,668 | 156,616,668 | ||||||||||||
1)
To record additional interest on the increased balance of debt totaling
$16,597 and amortization of increased discount totaling
$191,458.
|
|||||||||||||||
2)
To record loss on modification of convertible debt.
|
|||||||||||||||
3)
To expense increase in derivative liability due to the reduction in
conversion price of convertible debt and granting of warrants to purchase
40M shares of common shares.
|
For
the Six Months Ended
|
||||||||||||||||
June
30, 2008
|
||||||||||||||||
As
Originally Stated
|
Adjustments
|
As
Corrected
|
||||||||||||||
Revenues:
|
||||||||||||||||
Research
and development
|
$ | - | - | $ | - | |||||||||||
Revenue
from bridge testing
|